Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward C Keystone

Showing results (111-120 of 159) with videos related to

Pageof 16
Sort By:
The Journal of Rheumatology|July 19, 2011
Canadian recommendations for clinical trials of pharmacologic interventions in rheumatoid arthritis: inclusion criteria and study designJacob Karsh, Edward C Keystone, Boulos Haraoui, et al.
The Canadian Journal of Cardiology|April 16, 2022
Statin Use for Primary Cardiovascular Disease Prevention Is Low in Inflammatory ArthritisBindee Kuriya, Shadi Akhtari, Mohammad Movahedi, et al.
Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders|April 16, 2016
Reduction in Serum Uric Acid May Be Related to Methotrexate Efficacy in Early Rheumatoid Arthritis: Data from the Canadian Early Arthritis Cohort (CATCH)Jason J Lee, Vivian P Bykerk, George K Dresser, et al.
Annals of the Rheumatic Diseases|May 17, 2015
The comparative effectiveness of oral versus subcutaneous methotrexate for the treatment of early rheumatoid arthritisGlen S Hazlewood, J Carter Thorne, Janet E Pope, et al.
The Lancet. Rheumatology|January 17, 2024
Methotrexate withdrawal in patients with rheumatoid arthritis who achieve low disease activity with tofacitinib modified-release 11 mg once daily plus methotrexate (ORAL Shift): a randomised, phase 3b/4, non-inferiority trialStanley B Cohen, Janet Pope, Boulos Haraoui, et al.
Rheumatology (Oxford, England)|April 28, 2012
Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohortEmily McKeown, Vivian P Bykerk, Faye De Leon, et al.
The Journal of Rheumatology|March 3, 2011
Rapid improvement in the signs and symptoms of rheumatoid arthritis following certolizumab pegol treatment predicts better longterm outcomes: post-hoc analysis of a randomized controlled trialEdward C Keystone, Jeffrey R Curtis, Roy M Fleischmann, et al.
Annals of the Rheumatic Diseases|September 20, 2011
Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid arthritisPaul Emery, Désirée van der Heijde, Mikkel Ostergaard, et al.
Arthritis and Rheumatism|February 10, 2011
The effects of golimumab on radiographic progression in rheumatoid arthritis: results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapyPaul Emery, Roy Fleischmann, Désirée van der Heijde, et al.
Rheumatology (Oxford, England)|January 12, 2017
The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritisLillian J Barra, Janet E Pope, Carol Hitchon, et al.
Pageof 16

Showing results (111-120 of 159) with videos related to

Sort By:
Pageof 16
The Journal of Rheumatology|July 19, 2011
Canadian recommendations for clinical trials of pharmacologic interventions in rheumatoid arthritis: inclusion criteria and study designJacob Karsh, Edward C Keystone, Boulos Haraoui, et al.
The Canadian Journal of Cardiology|April 16, 2022
Statin Use for Primary Cardiovascular Disease Prevention Is Low in Inflammatory ArthritisBindee Kuriya, Shadi Akhtari, Mohammad Movahedi, et al.
Clinical Medicine Insights. Arthritis and Musculoskeletal Disorders|April 16, 2016
Reduction in Serum Uric Acid May Be Related to Methotrexate Efficacy in Early Rheumatoid Arthritis: Data from the Canadian Early Arthritis Cohort (CATCH)Jason J Lee, Vivian P Bykerk, George K Dresser, et al.
Annals of the Rheumatic Diseases|May 17, 2015
The comparative effectiveness of oral versus subcutaneous methotrexate for the treatment of early rheumatoid arthritisGlen S Hazlewood, J Carter Thorne, Janet E Pope, et al.
The Lancet. Rheumatology|January 17, 2024
Methotrexate withdrawal in patients with rheumatoid arthritis who achieve low disease activity with tofacitinib modified-release 11 mg once daily plus methotrexate (ORAL Shift): a randomised, phase 3b/4, non-inferiority trialStanley B Cohen, Janet Pope, Boulos Haraoui, et al.
Rheumatology (Oxford, England)|April 28, 2012
Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohortEmily McKeown, Vivian P Bykerk, Faye De Leon, et al.
The Journal of Rheumatology|March 3, 2011
Rapid improvement in the signs and symptoms of rheumatoid arthritis following certolizumab pegol treatment predicts better longterm outcomes: post-hoc analysis of a randomized controlled trialEdward C Keystone, Jeffrey R Curtis, Roy M Fleischmann, et al.
Annals of the Rheumatic Diseases|September 20, 2011
Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid arthritisPaul Emery, Désirée van der Heijde, Mikkel Ostergaard, et al.
Arthritis and Rheumatism|February 10, 2011
The effects of golimumab on radiographic progression in rheumatoid arthritis: results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapyPaul Emery, Roy Fleischmann, Désirée van der Heijde, et al.
Rheumatology (Oxford, England)|January 12, 2017
The effect of rheumatoid arthritis-associated autoantibodies on the incidence of cardiovascular events in a large inception cohort of early inflammatory arthritisLillian J Barra, Janet E Pope, Carol Hitchon, et al.
Pageof 16